Abstract

Osteocytes are mechanosensitive bone cells, but little is known about their effects on tumor cells in response to mechanical stimulation. We treated breast cancer cells with osteocyte-derived conditioned medium (CM) and fluid flow-treated conditioned medium (FFCM) with 0.25 Pa and 1 Pa shear stress. Notably, CM and FFCM at 0.25 Pa induced the mesenchymal-to-epithelial transition (MET), but FFCM at 1 Pa induced the epithelial-to-mesenchymal transition (EMT). This suggested that the effects of fluid flow on conditioned media depend on flow intensity. Fluorescence resonance energy transfer (FRET)-based evaluation of Src activity and vinculin molecular force showed that osteopontin was involved in EMT and MET switching. A mouse model of tumor-induced osteolysis was tested using dynamic tibia loadings of 1, 2, and 5 N. The low 1 N loading suppressed tumor-induced osteolysis, but this beneficial effect was lost and reversed with loads at 2 and 5 N, respectively. Changing the loading intensities in vivo also led to changes in serum TGFβ levels and the composition of tumor-associated volatile organic compounds in the urine. Collectively, this study demonstrated the critical role of intensity-dependent mechanotransduction and osteopontin in tumor-osteocyte communication, indicating that a biophysical factor can tangibly alter the behaviors of tumor cells in the bone microenvironment.

Details

Title
Skeletal loading regulates breast cancer-associated osteolysis in a loading intensity-dependent fashion
Author
Yao, Fan 1 ; Jalali Aydin 2 ; Chen, Andy 2   VIAFID ORCID Logo  ; Zhao, Xinyu 3 ; Liu Shengzhi 2 ; Teli Meghana 2 ; Guo Yunxia 1 ; Li Fangjia 4 ; Li, Junrui 5 ; Siegel, Amanda 6 ; Yang, Lianxiang 5 ; Liu, Jing 4 ; Na Sungsoo 2 ; Agarwal Mangilal 6 ; Robling, Alexander G 7 ; Nakshatri Harikrishna 8   VIAFID ORCID Logo  ; Bai-Yan, Li 9 ; Yokota Hiroki 10 

 Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268); Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China (GRID:grid.257413.6) 
 Indiana University Purdue University Indianapolis, Department of Physics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Oakland University, Department of Mechanical Engineering, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X) 
 Indiana University Purdue University Indianapolis, Integrative Nanosystems Development Institute, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Indiana University School of Medicine, Department of Anatomy and Cell Biology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Indiana Center for Musculoskeletal Health, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Indiana University School of Medicine, Department of Surgery, Simon Cancer Research Center, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268) 
10  Harbin Medical University, Department of Pharmacology, School of Pharmacy, Harbin, China (GRID:grid.410736.7) (ISNI:0000 0001 2204 9268); Indiana University Purdue University Indianapolis, Department of Biomedical Engineering, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Oakland University, Department of Mechanical Engineering, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X); Indiana University Purdue University Indianapolis, Integrative Nanosystems Development Institute, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Department of Anatomy and Cell Biology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Indiana Center for Musculoskeletal Health, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
Publication year
2020
Publication date
2020
Publisher
Springer Nature B.V.
ISSN
20954700
e-ISSN
20956231
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2355270361
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.